Frankly Speaking: Kat Wade chats about the challenges and opportunities in pharma marketing in 2024
We had the pleasure of sitting down with Kat Wade, an experienced pharma marketer, to explore the challenges and opportunities in the industry for 2024. Kat brings a wealth of experience having worked both agency-side to provide strategic counsel to clients delivering integrated campaigns, and also client-side as the Head of Retail at Zoetis.
In our conversation, Kat shared her insights on navigating the evolving
landscape of Australian pharma marketing, offering advice on getting bold and
innovative work approved and tips for fostering a strong client-agency
relationship. She highlights key challenges, including balancing audience content expectations with pharma’s risk-averse nature, and discusses strategies for overcoming these hurdles.
What are some of the biggest challenges and opportunities facing pharma marketers today?
For pharma marketers who want to do bold & innovative campaigns, what can they do help get their organisation onboard and content through approvals?
Having worked both pharma side and agency side, what do you think is important for a healthy and effective agency / client relationship?
Keen to hear more from Kat? Head over to her LinkedIn to connect.
Articles we think you'd like
Select a course to start your learning journey
Featured links
